Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Trishula Therapeutics, Inc.
Institut Bergonié
Intensity Therapeutics, Inc.
Rutgers, The State University of New Jersey
AIDS Malignancy Consortium
Novartis
Incyte Corporation
Institut Bergonié
Amgen
Novartis
Incyte Corporation
Amgen
Amgen
Altor BioScience